KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Petmed Express (PETS) EPS (Weighted Average and Diluted) (2016 - 2025)

Petmed Express has reported EPS (Weighted Average and Diluted) over the past 16 years, most recently at -$0.5 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 1566.67% year-over-year to -$0.5; the TTM value through Dec 2025 reached -$3.12, down 31300.0%, while the annual FY2025 figure was -$0.3, 18.92% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.5 at Petmed Express, down from -$0.41 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.34 in Q1 2021 and troughed at -$1.65 in Q2 2025.
  • A 5-year average of -$0.08 and a median of $0.01 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 400.0% in 2024 and fell as far as 2400.0% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.21 in 2021, then crashed by 104.76% to -$0.01 in 2022, then crashed by 900.0% to -$0.1 in 2023, then surged by 70.0% to -$0.03 in 2024, then plummeted by 1566.67% to -$0.5 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for PETS at -$0.5 in Q4 2025, -$0.41 in Q3 2025, and -$1.65 in Q2 2025.